Risankizumab vs. ustekinumab for plaque psoriasis: a critical appraisal

Al-Janabi, A; Labbar-Lopez, ZK; Griffiths, CEM; Yiu, ZZN

Al-Janabi, A (reprint author), Univ Manchester, Salford Royal NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Dermatol Ctr,NIHR Manchester Biomed Res Ctr, Manchester, Lancs, England.

BRITISH JOURNAL OF DERMATOLOGY, 2019; 180 (6): 1348

Abstract

Aim Gordon et al. investigated the efficacy and safety of risankizumab [an anti-interleukin (IL)-23p19 biologic] compared with ustekinumab (anti-IL-12......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索